The honors show “our dedication to providing timely, effective quality care to our patients in need,” said Dr. Koto Ishida, medical director for NYU Langone’s Comprehensive Stroke Center.
NYU Langone Health has been honored by the American Heart Association (AHA) for providing the fastest and most advanced stroke care in New York.
The Comprehensive Stroke Centers (CSCs), with locations in Manhattan, Brooklyn, and Long Island, along with the Stroke Center at NYU Langone Hospital—Suffolk, have each received the prestigious Get With The Guidelines®-Stroke Gold Plus Award for more than two consecutive years of outstanding care. This award is the highest recognition in stroke treatment, underscoring a consistent excellence across all campuses in combating the fifth leading cause of death in the United States.
“The recognition from the American Heart Association shows our dedication to providing timely, effective quality care to our patients in need,” said Koto Ishida, MD, medical director for NYU Langone’s Comprehensive Stroke Center. “Our multidisciplinary teams are trained to respond rapidly and effectively because time is brain—every second counts.”
In addition to the Gold Plus Award, the stroke centers have earned the following distinctions for meeting targets set by the AHA:
Every Comprehensive Stroke Center received these awards:
- Target: Stroke Elite Plus Honor Roll
- Target: Type 2 Diabetes Honor Roll
- Target: Stroke Advanced Therapy Honor Roll
The Stroke Center at NYU Langone—Suffolk received these awards:
- Target: Stroke Elite Honor Roll
- Target: Type 2 Diabetes Honor Roll
The CSCs have shown exceptional success in minimizing the time between a patient’s arrival and treatment. Recognized with the Stroke Elite Plus Honor Roll, at least 50 percent of patients received potentially lifesaving medication within 30 minutes, and 75 percent were treated within 45 minutes.
The CSCs also earned the Stroke Honor Roll Advanced Therapy award for its quick use of intervention devices, such as stent retrievers or thrombectomy tools, which serve as a vital second line of defense for complex stroke cases. At least half of these patients treated at a CSC location received device-based treatment within 90 minutes of arrival, and transferred patients were treated within 60 minutes.
Both the Stroke Center at NYU Langone—Suffolk and the CSCs were awarded the Type 2 Diabetes Honor Roll, for their work in improving stroke outcomes among patients with type 2 diabetes, a condition that significantly increases stroke risk.
At the Stroke Center, at least 85 percent of patients received medication within 60 minutes of arrival, earning the Stroke Honor Roll Elite distinction.
In addition to providing stroke care across locations, experts at NYU Langone’s diagnose, treat, and research a wide range of nervous system disorders. NYU Langone is ranked No. 1 in the United States for Neurology and by U.S. News and World Report.
About NYU Langone Health
NYU Langone Health is a fully integrated health system that consistently achieves the best patient outcomes through a rigorous focus on quality that has resulted in some of the lowest mortality rates in the nation. Vizient Inc. has ranked NYU Langone number one out of 115 comprehensive academic medical centers across the nation for three years in a row, and U.S. News & World Report recently ranked four of its clinical specialties number one in the nation. NYU Langone offers a comprehensive range of medical services with one high standard of care across 7 inpatient locations, its Perlmutter Cancer Center, and more than 320 outpatient locations in the New York area and Florida. With $14.2 billion in revenue this year, the system also includes two tuition-free medical schools, in Manhattan and on Long Island, and a vast research enterprise.
Media Inquiries
Julia Goodell
Julia.Goodell@NYULangone.org
Colin DeVries
Phone: 212-404-3588
Colin.DeVries@NYULangone.org
